1. Home
  2. THRY vs ENLV Comparison

THRY vs ENLV Comparison

Compare THRY & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Thryv Holdings Inc.

THRY

Thryv Holdings Inc.

HOLD

Current Price

$4.09

Market Cap

170.3M

Sector

Industrials

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$6.86

Market Cap

149.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THRY
ENLV
Founded
2012
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
170.3M
149.0M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
THRY
ENLV
Price
$4.09
$6.86
Analyst Decision
Buy
Buy
Analyst Count
4
2
Target Price
$9.33
$20.00
AVG Volume (30 Days)
564.6K
400.1K
Earning Date
04-30-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
100.50
N/A
EPS
0.10
N/A
Revenue
$785,015,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$43.20
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.91
$0.43
52 Week High
$14.28
$7.64

Technical Indicators

Market Signals
Indicator
THRY
ENLV
Relative Strength Index (RSI) 53.44 88.62
Support Level $3.27 $0.83
Resistance Level $4.19 N/A
Average True Range (ATR) 0.29 0.17
MACD 0.02 0.65
Stochastic Oscillator 66.52 87.66

Price Performance

Historical Comparison
THRY
ENLV

About THRY Thryv Holdings Inc.

Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable small and medium-sized business clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation. The group has two business segments; Thryv SaaS deriving maximum revenue and Thryv Marketing Services.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: